| Typicality: | 0.325 |
| Saliency: | 0.177 |
| down to 9 months | 2 | temporal |
| vaccine → be approved for → adult | 6 |
| vaccine → be approved for → age | 5 |
| negative | neutral | positive |
| 0.035 | 0.545 | 0.420 |
| Raw frequency | 11 |
| Normalized frequency | 0.177 |
| Modifier score | 0.500 |
| Perplexity | 62.357 |